Similar articles

• Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary.

  Mastorakos G, Webster EL, Friedman TC, Chrousos GP. Mastorakos G, et al. J Clin Invest. 1993 Aug;92(2):961-8. doi: 10.1172/JCI116672. J Clin Invest. 1993. PMID: 8394389 Free PMC article.
• Autocrine-paracrine role of ovarian corticotropin-releasing hormone.

  Mastorakos G, Ghizzoni L, Webster EL, Chrousos GP. Mastorakos G, et al. Ann N Y Acad Sci. 1997 Jun 17;816:27-41. doi: 10.1111/j.1749-6632.1997.tb52127.x. Ann N Y Acad Sci. 1997. PMID: 9238253 No abstract available.
• Corticotropin-releasing factor receptors: distribution and regulation in brain, pituitary, and peripheral tissues.

  Aguilera G, Millan MA, Hauger RL, Catt KJ. Aguilera G, et al. Ann N Y Acad Sci. 1987;512:48-66. doi: 10.1111/j.1749-6632.1987.tb24950.x. Ann N Y Acad Sci. 1987. PMID: 2831785 Review. No abstract available.
• Update on the role of ovarian corticotropin-releasing hormone.

  Kiapekou E, Zapanti E, Mastorakos G, Loutradis D. Kiapekou E, et al. Ann N Y Acad Sci. 2010 Sep;1205:225-9. doi: 10.1111/j.1749-6632.2010.05685.x. Ann N Y Acad Sci. 2010. PMID: 20840277 Review.
• Potential involvement of anxiety in the neurobiology of cocaine.

  Goeders NE. Goeders NE. Ann N Y Acad Sci. 1992 Jun 28;654:357-67. doi: 10.1111/j.1749-6632.1992.tb25981.x. Ann N Y Acad Sci. 1992. PMID: 1321577 Review. No abstract available.